Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Volz

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 2016
Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trialSiegfried Kasper, Hans-Peter Volz, Angelika Dienel, et al.
Psychopharmacology|November 9, 2002
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trialHans-Peter Volz, Harald Murck, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 12, 2002
Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophreniaHans-Peter Volz, Hans-Jürgen Möller, Alexandre Gerebtzoff, et al.
Psychiatry Research|May 31, 2002
Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groupsStefan Riehemann, Gabriele Hübner, Stefan Smesny, et al.
Advances in Therapy|February 20, 2017
Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily PracticeGerd Laux, Bettina Barthel, Göran Hajak, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 15, 2025
Silexan is well-tolerated for long-term use in adults and for treatment of adolescents: a real-world data analysisHans-Peter Volz, Thomas Rosemann, Martin Burkart, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2003
Neuroanatomy of "hearing voices": a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophreniaChristian Gaser, Igor Nenadic, Hans-Peter Volz, et al.
International Journal of Psychiatry in Clinical Practice|July 27, 2021
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature surveyHans-Peter Volz, Julia Saliger, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 19, 2017
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trialsHans-Jürgen Möller, Hans-Peter Volz, Angelika Dienel, et al.
International Clinical Psychopharmacology|April 6, 2017
Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data setSiegfried Kasper, Hans-Jürgen Möller, Hans-Peter Volz, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 2016
Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trialSiegfried Kasper, Hans-Peter Volz, Angelika Dienel, et al.
Psychopharmacology|November 9, 2002
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trialHans-Peter Volz, Harald Murck, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 12, 2002
Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophreniaHans-Peter Volz, Hans-Jürgen Möller, Alexandre Gerebtzoff, et al.
Psychiatry Research|May 31, 2002
Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groupsStefan Riehemann, Gabriele Hübner, Stefan Smesny, et al.
Advances in Therapy|February 20, 2017
Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily PracticeGerd Laux, Bettina Barthel, Göran Hajak, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 15, 2025
Silexan is well-tolerated for long-term use in adults and for treatment of adolescents: a real-world data analysisHans-Peter Volz, Thomas Rosemann, Martin Burkart, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2003
Neuroanatomy of "hearing voices": a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophreniaChristian Gaser, Igor Nenadic, Hans-Peter Volz, et al.
International Journal of Psychiatry in Clinical Practice|July 27, 2021
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature surveyHans-Peter Volz, Julia Saliger, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 19, 2017
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trialsHans-Jürgen Möller, Hans-Peter Volz, Angelika Dienel, et al.
International Clinical Psychopharmacology|April 6, 2017
Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data setSiegfried Kasper, Hans-Jürgen Möller, Hans-Peter Volz, et al.
Pageof 5